Latest AI and machine learning research in hemophilia for healthcare professionals.
Acetylcholinesterase (AChE) inhibition is a key mechanism in the treatment of neurodegenerative diseases and in counteracting toxic exposures to pesticides and nerve agents. However, virtual screening of AChE remains challenging due to the enzyme’s structural flexibility and the chemical diversity of its covalently binding inhibitors. In this study, we developed an in silico protocol that integrat...
The non-small cell lung cancer (NSCLC)-associated Epidermal Growth Factor Receptor (EGFR) mutant L858R/T790M confers resistance to first- and second-generation tyrosine kinase inhibitors (TKIs). Allosteric inhibitors, binding outside the ATP-binding site, have emerged as alternative therapeutic agents. Unlike orthosteric inhibitors, they preferentially stabilize EGFR in an inactive conformation. H...
Autophagy is a dynamic intracellular process that is essential in maintaining cellular homeostasis. Its potential as a therapeutic target is exemplifi...
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent condition characterized by fat build-up in the liver and ranges...
Adults and children with cerebral cavernous malformations (CCMs) are at risk of experiencing lifelong complications such as hemorrhagic strokes, neuro...
Disruption of the brain endothelial barrier is a hallmark of traumatic brain injury (TBI), and contributes to cerebral edema, coagulopathy, and delaye...
Molecular heterogeneity in head and neck squamous cell carcinoma (HNSCC) is well recognized, yet existing subtype frameworks remain largely descriptiv...
Several clinical prediction models have been developed using electronic health records data to help inform decisions about HIV pre-exposure prophylaxi...
Large language models (LLMs) have emerged as transformative technologies, revolutionizing natural language understanding and generation across various...
Fragile X Syndrome (FXS) is a rare neurodevelopmental disorder caused by a trinucleotide repeat expansion on the 5’ untranslated region of the FMR1 ge...
Clinical practice guidelines recommend cardiovascular toxicity risk restratification including evaluation of new cardiovascular risk factors and cardi...
Chatbots have the potential to reduce barriers to pre-exposure prophylaxis (PrEP), including lack of awareness, misconceptions, and stigma, by providi...
Determination of cardiac output (CO) is essential to the clinical management of cardiovascular compromise. However, the invasiveness, procedural risks...
Development of anti-drug antibodies (ADAs) is a barrier to long-term efficacy of biologic therapies in rheumatoid arthritis (RA), but no biomarkers ex...
This scoping review explores how predictive modelling can strengthen pre-exposure prophylaxis (PrEP) uptake among high-risk populations in Africa, whe...
Tuberculosis remains a major health threat, infecting nearly a third of the world’s population. Of those infected, 5-10% progress from latent infectio...
Buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel, demonstrated improved survival in the BERIL-1 trial for patients with recurrent/me...
Immunotherapy has improved outcomes for advanced-stage melanoma, however, predictive biomarkers remain limited. We evaluated whether computed tomograp...
Immunotherapy has improved outcomes in non-small cell lung cancer (NSCLC), but only a subset of patients achieves durable survival benefit. Convention...
Development of oral, broad-spectrum therapeutics targeting SARS-CoV-2, its variants, and related coronaviruses could curb the spread of COVID-19 and a...